Dev Prasad
Stock Analyst at LUCID CAPITAL MARKETS
(0.26)
# 4,264
Out of 4,960 analysts
4
Total ratings
25%
Success rate
-13.63%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Dev Prasad
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IRD Opus Genetics | Initiates: Buy | $5 | $1.15 | +334.78% | 1 | Jun 17, 2025 | |
| AVTX Avalo Therapeutics | Initiates: Buy | $24 | $9.88 | +142.91% | 1 | Dec 17, 2024 | |
| IBIO iBio, Inc. | Initiates: Buy | $6 | $0.79 | +658.53% | 1 | Dec 17, 2024 | |
| CALC CalciMedica | Initiates: Buy | $13 | $2.78 | +367.63% | 1 | Dec 17, 2024 |
Opus Genetics
Jun 17, 2025
Initiates: Buy
Price Target: $5
Current: $1.15
Upside: +334.78%
Avalo Therapeutics
Dec 17, 2024
Initiates: Buy
Price Target: $24
Current: $9.88
Upside: +142.91%
iBio, Inc.
Dec 17, 2024
Initiates: Buy
Price Target: $6
Current: $0.79
Upside: +658.53%
CalciMedica
Dec 17, 2024
Initiates: Buy
Price Target: $13
Current: $2.78
Upside: +367.63%